Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the Acetylcholinesterase Inhibitor, Galantamine, on Short-term Abstinence

NCT01548638 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT01548638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01548638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the Acetylcholinesterase Inhibitor, Galantamine, on Short-term Abstinence
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
October 31, 2013
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine addiction